Citation: | LIU Miaomiao, YUE Hongmei, LI Yating, XU Jinhui, WU Xingdong, ZHU Haobin. Obstructive Sleep Apnea-induced Gut Dysbiosis and Ischaemic Stroke: Mechanism and Research Progress[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 382-386. DOI: 10.12290/xhyxzz.2023-0452 |
[1] |
Pan Z J, Ma T P, Zeng Q H, et al. People's knowledge, attitudes, practice, and healthcare education demand regard-ing OSA: a cross-sectional study among Chinese general populations[J]. Front Public Health, 2023, 11: 1128334. DOI: 10.3389/fpubh.2023.1128334
|
[2] |
Javaheri S, Peker Y, Yaggi H K, et al. Obstructive sleep apnea and stroke: the mechanisms, the randomized trials, and the road ahead[J]. Sleep Med Rev, 2022, 61: 101568. DOI: 10.1016/j.smrv.2021.101568
|
[3] |
Sanchez O, Adra N, Chuprevich S, et al. Screening for OSA in stroke patients: the role of a sleep educator[J]. Sleep Med, 2022, 100: 196-197. DOI: 10.1016/j.sleep.2022.08.024
|
[4] |
Okubo H, Nakatsu Y, Kushiyama A, et al. Gut microbiota as a therapeutic target for metabolic disorders[J]. Curr Med Chem, 2018, 25(9): 984-1001. DOI: 10.2174/0929867324666171009121702
|
[5] |
Berding K, Vlckova K, Marx W, et al. Diet and the microbiota-gut-brain axis: sowing the seeds of good mental health[J]. Adv Nutr, 2021, 12(4): 1239-1285. DOI: 10.1093/advances/nmaa181
|
[6] |
Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea[J]. Expert Opin Ther Targets, 2020, 24(12): 1263-1282. DOI: 10.1080/14728222.2020.1841749
|
[7] |
Fava F, Rizzetto L, Tuohy K M. Gut microbiota and health: connecting actors across the metabolic system[J]. Proc Nutr Soc, 2019, 78(2): 177-188. DOI: 10.1017/S0029665118002719
|
[8] |
Cai Y, Juszczak H M, Cope E K, et al. The microbiome in obstructive sleep apnea[J]. Sleep, 2021, 44(8): zsab061. DOI: 10.1093/sleep/zsab061
|
[9] |
Poroyko V A, Carreras A, Khalyfa A, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice[J]. Sci Rep, 2016, 6: 35405. DOI: 10.1038/srep35405
|
[10] |
Xue J, Allaband C, Zhou D, et al. Influence of intermittent hypoxia/hypercapnia on atherosclerosis, gut microbiome, and metabolome[J]. Front Physiol, 2021, 12: 663950. DOI: 10.3389/fphys.2021.663950
|
[11] |
Zeng J S, Yang K L, Nie H F, et al. The mechanism of intestinal microbiota regulating immunity and inflammation in ischemic stroke and the role of natural botanical active ingredients in regulating intestinal microbiota: a review[J]. Biomed Pharmacother, 2023, 157: 114026. DOI: 10.1016/j.biopha.2022.114026
|
[12] |
Hu W J, Kong X Y, Wang H, et al. Ischemic stroke and intestinal flora: an insight into brain-gut axis[J]. Eur J Med Res, 2022, 27(1): 73. DOI: 10.1186/s40001-022-00691-2
|
[13] |
Sharma V, Sharma V, Shahjouei S, et al. At the intersection of gut microbiome and stroke: a systematic review of the literature[J]. Front Neurol, 2021, 12: 729399. DOI: 10.3389/fneur.2021.729399
|
[14] |
Nam H S. Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide[J]. J Stroke, 2019, 21(2): 151-159. DOI: 10.5853/jos.2019.00472
|
[15] |
Zhu W F, Gregory J C, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell, 2016, 165(1): 111-124. DOI: 10.1016/j.cell.2016.02.011
|
[16] |
El Hage R, Al-Arawe N, Hinterseher I. The role of the gut microbiome and trimethylamine oxide in atherosclerosis and age-related disease[J]. Int J Mol Sci, 2023, 24(3): 2399. DOI: 10.3390/ijms24032399
|
[17] |
Zhang J L, Wang L K, Cai J L, et al. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke[J]. J Neuroimmunol, 2021, 354: 577526. DOI: 10.1016/j.jneuroim.2021.577526
|
[18] |
Mirzaei R, Bouzari B, Hosseini-Fard S R, et al. Role of microbiota-derived short-chain fatty acids in nervous system disorders[J]. Biomed Pharmacother, 2021, 139: 111661. DOI: 10.1016/j.biopha.2021.111661
|
[19] |
Tan C H, Wu Q H, Wang H D, et al. Dysbiosis of gut microbiota and short-chain fatty acids in acute ischemic stroke and the subsequent risk for poor functional outcomes[J]. JPEN J Parenter Enteral Nutr, 2021, 45(3): 518-529. DOI: 10.1002/jpen.1861
|
[20] |
Lee J, D'Aigle J, Atadja L, et al. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice[J]. Circ Res, 2020, 127(4): 453-465. DOI: 10.1161/CIRCRESAHA.119.316448
|
[21] |
Li P, Dong Z Y, Chen W H, et al. Causal relations between obstructive sleep apnea and stroke: a mendelian randomiza-tion study[J]. Nat Sci Sleep, 2023, 15: 257-266. DOI: 10.2147/NSS.S398544
|
[22] |
Zhao L N, Yang L J, Guo Y Y, et al. New insights into stroke prevention and treatment: gut microbiome[J]. Cell Mol Neurobiol, 2022, 42(2): 455-472. DOI: 10.1007/s10571-021-01047-w
|
[23] |
Xue J, Zhou D, Poulsen O, et al. Intermittent hypoxia and hypercapnia accelerate atherosclerosis, partially via trimethylamine-oxide[J]. Am J Respir Cell Mol Biol, 2017, 57(5): 581-588. DOI: 10.1165/rcmb.2017-0086OC
|
[24] |
Wang Z N, Klipfell E, Bennett B J, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341): 57-63. DOI: 10.1038/nature09922
|
[25] |
Ding L, Chang M R, Guo Y, et al. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism[J]. Lipids Health Dis, 2018, 17(1): 286. DOI: 10.1186/s12944-018-0939-6
|
[26] |
Xia W Y, Huang Y H, Peng B, et al. Relationship between obstructive sleep apnoea syndrome and essential hypertension: a dose-response meta-analysis[J]. Sleep Med, 2018, 47: 11-18. DOI: 10.1016/j.sleep.2018.03.016
|
[27] |
Munir S S, Sert Kuniyoshi F H, Singh P, et al. Is the gut microbiome implicated in the excess risk of hypertension associated with obstructive sleep apnea? A contemporary review[J]. Antioxidants (Basel), 2023, 12(4): 866. DOI: 10.3390/antiox12040866
|
[28] |
Durgan D J. Obstructive sleep apnea-induced hypertension: role of the gut microbiota[J]. Curr Hypertens Rep, 2017, 19(4): 35.
|
[29] |
Jiao Y, Li W X, Zhang Q Y, et al. Gut microbiota and hypertension: a bibliometric analysis of recent research (2014—2023)[J]. Front Nutr, 2023, 10: 1253803. DOI: 10.3389/fnut.2023.1253803
|
[30] |
Liu J, Li T X, Wu H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type Ⅰ inflammation[J]. Biomed Pharmacother, 2019, 112: 108580.
|
[31] |
伍娟, 杨眉峰, 楼莹, 等. 肠道微生物与阻塞性睡眠呼吸暂停低通气综合征及其并发症的相关性研究进展[J]. 江西中医药大学学报, 2019, 31(6): 117-121. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXB201906036.htm
Wu J, Yang M F, Lou Y, et al. Research progress of correlation between intestinal microorganism and OSAHS and its complications[J]. J Jiangxi Univ Tradit Chin Med, 2019, 31(6): 117-121. https://www.cnki.com.cn/Article/CJFDTOTAL-XYXB201906036.htm
|
[32] |
Khalyfa A, Ericsson A, Qiao Z H, et al. Circulating exosomes and gut microbiome induced insulin resistance in mice exposed to intermittent hypoxia: effects of physical activity[J]. EBioMedicine, 2021, 64: 103208.
|
[33] |
Pack A I. Gut microbiome: role in insulin resistance in obstructive sleep apnea[J]. EBioMedicine, 2021, 65: 103278.
|
1. |
任凯利,樊如燕,师艳红,张燕,郭景慧,刘玉玲. 天然产物活性成分缓解酒精性肝损伤的研究进展. 医学理论与实践. 2025(04): 576-578+582 .
![]() | |
2. |
党文珊,罗婧,张慧君,王艺讳,宋林林. 阻塞性睡眠呼吸暂停综合征对缺血性脑卒中患者的影响. 中国卫生标准管理. 2024(18): 102-105 .
![]() |